CL2009000911A1 - Cepa de lactobacillus paracasei con numero de registro cncm 1-3689 que posee propiedades antimicrobianas e inmunomoduladoras; procedimiento de obtencion; y composicion que comprende dicha cepa. - Google Patents

Cepa de lactobacillus paracasei con numero de registro cncm 1-3689 que posee propiedades antimicrobianas e inmunomoduladoras; procedimiento de obtencion; y composicion que comprende dicha cepa.

Info

Publication number
CL2009000911A1
CL2009000911A1 CL2009000911A CL2009000911A CL2009000911A1 CL 2009000911 A1 CL2009000911 A1 CL 2009000911A1 CL 2009000911 A CL2009000911 A CL 2009000911A CL 2009000911 A CL2009000911 A CL 2009000911A CL 2009000911 A1 CL2009000911 A1 CL 2009000911A1
Authority
CL
Chile
Prior art keywords
strain
composition
antimicrobial
lactobacillus paracasei
obtaining
Prior art date
Application number
CL2009000911A
Other languages
English (en)
Inventor
Chambaud Isabelle
Villain Anne-Catherine
Khlebnikov Artem
Grompone Gianfranco
Saint-Denis Thierry
Smokvina Tamara
Druesne Anne
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Publication of CL2009000911A1 publication Critical patent/CL2009000911A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Animal Husbandry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

CEPA DE LACTOBACILLUS PARACASEI SUBSP. PARACASEI CNCM 1-3689, QUE POSEE PROPIEDADES ANTIMICROBIANAS E INMUNOMODULADORAS, SUSCEPTIBLE DE OBTENCIÓN POR MUTAGÉNESIS O TRANSFORMACIÓN GENÉTICA. SE REIVINDICA TAMBIÉN UN PROCEDIMIENTO PARA LA OBTENCIÓN DE DICHA CEPA Y UN PROCEDIMIENTO PARA OBTENER UNA FRACCIÓN CELULAR DE LA MISMA, SIENDO DICHA FRACCIÓN CELULAR ES SELECCIONADO A PARTIR DEL GRUPO CONSISTENTE EN UN PREPARADO DE ADN, UN PREPARADO DE PARED BACTERIANA, UNOS RESIDUOS LIQUIDO DE CULTIVO, O UNA FRACCIÓN DE DICHO RESIDUOS LÍQUIDOS. SE PROPORCIONA ADEMÁS UNA COMPOSICIÓN, QUE ES UN PRODUCTO ALIMENTICIO, COMPRENDIENDO LA CEPA ANTES DESCRITA.
CL2009000911A 2008-04-18 2009-04-16 Cepa de lactobacillus paracasei con numero de registro cncm 1-3689 que posee propiedades antimicrobianas e inmunomoduladoras; procedimiento de obtencion; y composicion que comprende dicha cepa. CL2009000911A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0802158A FR2930264B1 (fr) 2008-04-18 2008-04-18 Nouvelle souche de lactobacillus paracasei subsp. paracasei dotee de proprietes antimicrobiennes et immunomodulatrices.

Publications (1)

Publication Number Publication Date
CL2009000911A1 true CL2009000911A1 (es) 2010-02-19

Family

ID=39720249

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009000911A CL2009000911A1 (es) 2008-04-18 2009-04-16 Cepa de lactobacillus paracasei con numero de registro cncm 1-3689 que posee propiedades antimicrobianas e inmunomoduladoras; procedimiento de obtencion; y composicion que comprende dicha cepa.

Country Status (16)

Country Link
US (1) US8557561B2 (es)
EP (1) EP2271744B1 (es)
JP (1) JP5649564B2 (es)
KR (1) KR101609401B1 (es)
CN (1) CN102066550B (es)
AR (1) AR071330A1 (es)
BR (1) BRPI0911420A8 (es)
CA (1) CA2721704C (es)
CL (1) CL2009000911A1 (es)
ES (1) ES2410263T3 (es)
FR (1) FR2930264B1 (es)
MX (1) MX2010011465A (es)
PL (1) PL2271744T3 (es)
RU (1) RU2501850C2 (es)
WO (1) WO2009130423A2 (es)
ZA (1) ZA201007510B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8372392B2 (en) * 2009-12-23 2013-02-12 Lytone Enterprise, Inc. Lactobacillus paracasei strain LT12 as immunity regulatory agent
WO2011141762A1 (en) 2010-05-12 2011-11-17 Compagnie Gervais Danone Synergistic fermentation of lactobacillus rhamnosus and lactobacillus paracasei subsp paracasei
US20130149415A1 (en) 2010-07-15 2013-06-13 Laurent Marchal Use of manganese for enhancing the growth of L.casei in mixed cultures.
CN102604854B (zh) * 2010-12-08 2014-06-18 益擎生技有限公司 新颖乳酸菌株及其调节免疫反应的用途
WO2012133827A1 (ja) * 2011-03-31 2012-10-04 森永乳業株式会社 新規乳酸菌、並びに新規乳酸菌を含有する医薬、飲食品、及び飼料
PT2693885T (pt) * 2011-04-08 2018-06-04 Chr Hansen As Efeito antimicrobiano sinérgico
EP2731617A4 (en) 2011-07-12 2015-07-01 Brigham & Womens Hospital LIPID-BASED PSA COMPOSITIONS, METHOD FOR THEIR INSULATION AND USE METHOD THEREFOR
WO2013019896A1 (en) * 2011-08-01 2013-02-07 Symbiotix Biotherapies, Inc. Platform for identifying and/or characterizing immunomodulatory agents
ES2402014B1 (es) * 2011-09-07 2014-02-27 Consejo Superior De Investigaciones Científicas (Csic) Peptido secretado por lactobacillus plantarum con función inmunomoduladora
US20140294791A1 (en) * 2011-12-01 2014-10-02 Institut Pasteur Lactobacillus paracasei subsp. paracasei, as an agent for inhibiting listeria monocytogenes in vivo infection
WO2013174792A1 (en) 2012-05-21 2013-11-28 Dupont Nutrition Biosciences Aps Strains of lactobacillus with antifungal properties
US10760064B2 (en) 2013-03-15 2020-09-01 The General Hospital Corporation RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
US10378027B2 (en) 2013-03-15 2019-08-13 The General Hospital Corporation RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
WO2014204578A1 (en) 2013-06-21 2014-12-24 The General Hospital Corporation Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing
ES2660813T3 (es) 2013-07-12 2018-03-26 Morinaga Milk Industry Co., Ltd. Nueva bacteria de ácido láctico, fármaco, producto alimenticio o bebida, y pienso que contienen la nueva bacteria de ácido láctico
CN104673700A (zh) * 2013-11-29 2015-06-03 晨晖生物科技股份有限公司 乳酸菌株及引物组
CN104862240A (zh) * 2013-12-28 2015-08-26 萧夏青 乳酸菌株及其引物组
WO2015159124A1 (en) 2014-04-15 2015-10-22 Compagnie Gervais Danone Use of lactobacillus paracasei for promoting intestinal clearance of opportunistic pathogens after antibiotic dysbiosis
CN104523762B (zh) * 2014-12-10 2019-01-22 中国农业大学 具有抗过敏作用的副干酪乳杆菌的应用和功能食品组合物及其制备方法
GB201506509D0 (en) 2015-04-16 2015-06-03 Univ Wageningen Nuclease-mediated genome editing
US9790490B2 (en) * 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
US10648020B2 (en) 2015-06-18 2020-05-12 The Broad Institute, Inc. CRISPR enzymes and systems
JP6918365B2 (ja) 2015-08-19 2021-08-11 プレジデント アンド フェローズ オブ ハーバード カレッジ 脂質化ｐｓａ組成物および方法
US9926546B2 (en) 2015-08-28 2018-03-27 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
US9512446B1 (en) 2015-08-28 2016-12-06 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
US12110490B2 (en) 2015-12-18 2024-10-08 The Broad Institute, Inc. CRISPR enzymes and systems
BR112018014104B1 (pt) * 2016-01-21 2022-11-29 Chr. Hansen A/S Método de produzir um produto lácteo fermentado,composição e produto alimentício
SG11201810179RA (en) 2016-04-19 2018-12-28 Broad Inst Inc Novel crispr enzymes and systems
AU2017253107B2 (en) 2016-04-19 2023-07-20 Massachusetts Institute Of Technology CPF1 complexes with reduced indel activity
US11606965B2 (en) 2016-05-11 2023-03-21 Chr. Hansen A/S Lactic acid bacteria for a heat-treated food product for storage at ambient temperature
US11491181B2 (en) 2016-07-15 2022-11-08 President And Fellows Of Harvard College Glycolipid compositions and methods of use
RU2744271C2 (ru) * 2016-12-16 2021-03-04 Компани Жервэ Данон Пробиотическая композиция, содержащая штаммы Lactobacillus rhamnosus и Lactobacillus paracasei
US20230183388A1 (en) * 2017-06-09 2023-06-15 Asahi Kohsan Corporation Exopolysaccharide of lactic acid bacterium and use thereof
US11447740B2 (en) 2017-06-09 2022-09-20 Sone Farm Co., Ltd. Lactic acid bacterium and use thereof
WO2019147743A1 (en) 2018-01-26 2019-08-01 Massachusetts Institute Of Technology Structure-guided chemical modification of guide rna and its applications
KR102463809B1 (ko) * 2019-05-24 2022-11-04 한국식품연구원 클로스트리디오이데스 디피실레에 항균 활성을 갖는 락토바실러스 파라카세이 WiKim0110 균주 및 이를 포함하는 조성물
CA3142908A1 (en) * 2019-06-07 2020-12-10 Universite De Lille Novel lactic acid bacteria strain - antibacterial peptides produced by said strain and related pharmaceutical compositions
CN110878270B (zh) * 2019-12-21 2021-08-13 福建省农业科学院农业工程技术研究所 一株副干酪乳杆菌副干酪亚种及其应用
WO2025032353A1 (en) 2023-08-04 2025-02-13 Compagnie Gervais Danone Symbiotic fermented milk products containing a probiotic and storage-stable in situ produced galacto-oligosaccharides
CN117070425B (zh) * 2023-10-10 2024-03-08 广东益可维生物技术有限公司 提高益生菌在机体内代谢稳定性的工艺方法及益生菌冻干粉

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2126962T3 (es) * 1995-01-02 1999-04-01 Gervais Danone Co Fermento lactico, y su uso para la preparacion de productos antidiarreicos.
SE510813C2 (sv) * 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
KR100419132B1 (ko) * 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
FR2848115B1 (fr) * 2002-12-05 2005-03-25 Rhodia Chimie Sa Composition de bacteries et son utilisation
US7919277B2 (en) * 2004-04-28 2011-04-05 Danisco A/S Detection and typing of bacterial strains
SE529185C2 (sv) * 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
WO2008047391A1 (en) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Nutriceutic composition comprising lactoferrin and proteasic probiotics

Also Published As

Publication number Publication date
JP5649564B2 (ja) 2015-01-07
PL2271744T3 (pl) 2013-08-30
US8557561B2 (en) 2013-10-15
CN102066550A (zh) 2011-05-18
CA2721704A1 (fr) 2009-10-29
WO2009130423A3 (fr) 2009-12-17
FR2930264B1 (fr) 2013-02-22
EP2271744B1 (fr) 2013-03-20
US20110150852A1 (en) 2011-06-23
CA2721704C (fr) 2019-04-02
RU2010146956A (ru) 2012-05-27
MX2010011465A (es) 2011-01-21
KR20110009152A (ko) 2011-01-27
FR2930264A1 (fr) 2009-10-23
RU2501850C2 (ru) 2013-12-20
AR071330A1 (es) 2010-06-09
CN102066550B (zh) 2013-10-30
ZA201007510B (en) 2011-08-31
WO2009130423A2 (fr) 2009-10-29
BRPI0911420A2 (pt) 2015-08-04
BRPI0911420A8 (pt) 2016-06-28
JP2011517570A (ja) 2011-06-16
KR101609401B1 (ko) 2016-04-05
EP2271744A2 (fr) 2011-01-12
ES2410263T3 (es) 2013-07-01

Similar Documents

Publication Publication Date Title
CL2009000649A1 (es) Cepa de lactobacillus rhamnosus cncm i-3690 con propiedades antimicrobianas e inmunomoduladoras; fraccion celular de la misma; y composicion que la comprende.
AR071330A1 (es) Cepa de lactobacillus paracasei subsp paracasei dotada de propiedades antimicrobianas e inmunomoduladoras
MX2022003373A (es) Composiciones a base de cepas bacterianas y su uso como antiinflamatorios.
Teneva-Angelova et al. Lactic acid bacteria—from nature through food to health
SE1550189A1 (en) Therapeutic and prophylactic composition produced by microbiota
ES2524432T3 (es) Bacterias del ácido láctico como cepas probióticas y composiciones que contienen las mismas
MX347262B (es) Preparaciones de alimento para mascotas que contienen microorganismos probióticos.
MX2018007773A (es) Uso de una lactasa en la preparación de un producto lácteo fermentado filtrado.
WO2016061377A3 (en) Lepidopteran-active cry1da1 amino acid sequence variant proteins
RU2014129803A (ru) Новый штамм lactobacillus mucosae
Liu et al. The chemistry and bioactivity of macrolides from marine microorganisms
WO2009098411A3 (fr) Utilisation de l. casei ssp. paracasei comme antifongique
IN2012DN03024A (es)
YANG et al. Isolation and identification of lactic acid bacteria in pickled vegetables from Meishan city
ZHANG et al. Screening and identification of lactic acid bacterium with antimicrobial and antioxidant activity
RU2014142843A (ru) Способ силосования трав биологическим консервантом "фербак-сил б-1"
ZHANG et al. Bacterial diversity analysis and isolation and identification of lactic acid bacteria from Jiangshui, a traditional Chinese fermented vegetable product
RU2005125534A (ru) Продукция витамина в12 в кисломолочных продуктах
WO2014081320A8 (en) A new strain of lactobacillus buchneri a, composition, a multi-component preparation for starch-rich plant preservation, their use and a method for plant preservation.
Jiang et al. Water-soluble chemical constituents of Angelica sinensis (Oliv.) Diels
Israyelyan COMPARATIVE CHARACTERIZATION OF ENDEMIC LACTIC ACID BACTERIA OF ENTEROCOCCUS GENUS FROM COW'S MILK
WO2009098592A3 (en) Preparation comprising mycobacterium bovis bcg killed by extended freeze drying (efd) for preventing or treating rheumatoid arthritis.
Zhang XiangMei et al. Screening and identification of lactic acid bacterium with antimicrobial and antioxidant activity.
RU2015130507A (ru) Способ получения ферментированного растительного сырья
RU2015114623A (ru) Применение консорциума молочнокислых бактерий Lactobacillus для обезгорчивания экстрактов хвои, способ получения сброженного напитка из хвойного экстракта и сброженный напиток